Pfizer vaccine meets criteria for success, FDA says

Posted on AllSides December 8th, 2020
From The Right

The Food and Drug Administration signaled Tuesday that it is likely to approve emergency use authorization for the Pfizer/BioNTech coronavirus vaccine.

In a detailed analysis released Tuesday morning, the FDA said that it could find “no specific safety concerns identified that would preclude issuance of an EUA.”

A majority did experience side effects commonly associated with vaccines, including fatigue, headaches, and pain at the injection site.

On Thursday, the FDA will hold a meeting of its Vaccines and Related Biological Products Advisory Committee, known as VRBPAC, to determine whether the...

Read full story
Some content from this outlet may be limited or behind a paywall.

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right